Multiple sclerosis: New help, new hope

David C Hess, Mary D. Hughes

Research output: Contribution to journalReview articlepeer-review


Immunomodulatory agents reduce the rate of relapse in patients with relapsing-remitting multiple (MS); in addition, these drugs, particularly the interferons, can slow the progression of the disease. Thus, early treatment can help prevent disability. High doses of corticosteroids given early during an MS relapse may decrease the length and severity of the attack. Mitoxantrone is generally reserved for patients with progressive forms of MS who are experiencing rapid loss functioning. Consider intravenous immunoglobulin for patients who have had steady disease progression. Combinations of either an interferon or glatiramer with oral immunosuppresant or pulse corticosteroid therapy are increasingly used.

Original languageEnglish (US)
Pages (from-to)1144-1148
Number of pages5
Issue number10
StatePublished - Sep 1 2005


  • Immunomodulatory therapy
  • Multiple sclerosis
  • Rehabilitation

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Multiple sclerosis: New help, new hope'. Together they form a unique fingerprint.

Cite this